James Thomas Coates is a Senior Director at AstraZeneca, where they apply scientific expertise and leadership skills to advance solutions for challenging health issues. They completed a PhD in Radiation Oncology & Biology from the University of Oxford, where they also obtained a Master of Science with Distinction. Previously, James served as a Research Fellow at Harvard Medical School and Massachusetts General Hospital, publishing significant research on acquired resistance in breast cancer therapy. They held roles as a Principal at Decisive Point and a Fellow for Ending Bioweapons at The Council on Strategic Risks, reflecting their commitment to addressing systemic security risks and advancing deep-tech innovations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices